Heart Failure Association of the European Society of Cardiology update on sodium-glucose co-transporter 2 inhibitors in heart failure (an update on the sodium-glucose co-transporter 2 inhibitors in heart failure: beyond glycaemic control. A position paper of the Heart Failure Association of the European Society of Cardiology)
EUROPEAN JOURNAL OF HEART FAILURE, cilt.22, sa.11, ss.1984-1986, 2020 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 22 Sayı: 11
- Basım Tarihi: 2020
- Doi Numarası: 10.1002/ejhf.2026
- Dergi Adı: EUROPEAN JOURNAL OF HEART FAILURE
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, EMBASE, MEDLINE
- Sayfa Sayıları: ss.1984-1986
- Anahtar Kelimeler: Heart failure, Sodium–, glucose co‐, transporter 2 inhibitors, Type 2 diabetes mellitus, Cardiovascular outcomes, Renal function
- Eskişehir Osmangazi Üniversitesi Adresli: Evet
Özet
The Heart Failure Association (HFA) of the European Society of Cardiology (ESC) has recently issued a position paper on the role of sodium-glucose co-transporter 2 (SGLT2) inhibitors in heart failure (HF). The present document provides an update of the position paper, based of new clinical trial evidence. Accordingly, the following recommendations are given: